Overview

To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To examine the lung when people with diabetes take an inhaled form of insulin, compared to subcutaneous insulin.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Collaborator:
Sanofi
Treatments:
Insulin
Insulin, Globin Zinc